SARS-CoV-2 tests, confirmed infections and COVID-19-related hospital admissions in children and young people: birth cohort study.
COVID-19
epidemiology
Journal
BMJ paediatrics open
ISSN: 2399-9772
Titre abrégé: BMJ Paediatr Open
Pays: England
ID NLM: 101715309
Informations de publication
Date de publication:
08 2022
08 2022
Historique:
received:
13
05
2022
accepted:
05
08
2022
entrez:
2
9
2022
pubmed:
3
9
2022
medline:
9
9
2022
Statut:
ppublish
Résumé
There have been no population-based studies of SARS-CoV-2 testing, PCR-confirmed infections and COVID-19-related hospital admissions across the full paediatric age range. We examine the epidemiology of SARS-CoV-2 in children and young people (CYP) aged <23 years. We used a birth cohort of all children born in Scotland since 1997, constructed via linkage between vital statistics, hospital records and SARS-CoV-2 surveillance data. We calculated risks of tests and PCR-confirmed infections per 1000 CYP-years between August and December 2020, and COVID-19-related hospital admissions per 100 000 CYP-years between February and December 2020. We used Poisson and Cox proportional hazards regression models to determine risk factors. Among the 1 226 855 CYP in the cohort, there were 378 402 tests (a rate of 770.8/1000 CYP-years (95% CI 768.4 to 773.3)), 19 005 PCR-confirmed infections (179.4/1000 CYP-years (176.9 to 182.0)) and 346 admissions (29.4/100 000 CYP-years (26.3 to 32.8)). Infants had the highest COVID-19-related admission rates. The presence of chronic conditions, particularly multiple types of conditions, was strongly associated with COVID-19-related admissions across all ages. Overall, 49% of admitted CYP had at least one chronic condition recorded. Infants and CYP with chronic conditions are at highest risk of admission with COVID-19. Half of admitted CYP had chronic conditions. Studies examining COVID-19 vaccine effectiveness among children with chronic conditions and whether maternal vaccine during pregnancy prevents COVID-19 admissions in infants are urgently needed.
Sections du résumé
BACKGROUND
There have been no population-based studies of SARS-CoV-2 testing, PCR-confirmed infections and COVID-19-related hospital admissions across the full paediatric age range. We examine the epidemiology of SARS-CoV-2 in children and young people (CYP) aged <23 years.
METHODS
We used a birth cohort of all children born in Scotland since 1997, constructed via linkage between vital statistics, hospital records and SARS-CoV-2 surveillance data. We calculated risks of tests and PCR-confirmed infections per 1000 CYP-years between August and December 2020, and COVID-19-related hospital admissions per 100 000 CYP-years between February and December 2020. We used Poisson and Cox proportional hazards regression models to determine risk factors.
RESULTS
Among the 1 226 855 CYP in the cohort, there were 378 402 tests (a rate of 770.8/1000 CYP-years (95% CI 768.4 to 773.3)), 19 005 PCR-confirmed infections (179.4/1000 CYP-years (176.9 to 182.0)) and 346 admissions (29.4/100 000 CYP-years (26.3 to 32.8)). Infants had the highest COVID-19-related admission rates. The presence of chronic conditions, particularly multiple types of conditions, was strongly associated with COVID-19-related admissions across all ages. Overall, 49% of admitted CYP had at least one chronic condition recorded.
CONCLUSIONS
Infants and CYP with chronic conditions are at highest risk of admission with COVID-19. Half of admitted CYP had chronic conditions. Studies examining COVID-19 vaccine effectiveness among children with chronic conditions and whether maternal vaccine during pregnancy prevents COVID-19 admissions in infants are urgently needed.
Identifiants
pubmed: 36053647
pii: 10.1136/bmjpo-2022-001545
doi: 10.1136/bmjpo-2022-001545
pmc: PMC9437731
pii:
doi:
Substances chimiques
COVID-19 Vaccines
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Medical Research Council
ID : MR/T016558/1
Pays : United Kingdom
Informations de copyright
© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
N Engl J Med. 2021 Dec 2;385(23):2132-2139
pubmed: 34614329
JAMA. 2020 Jul 21;324(3):259-269
pubmed: 32511692
BMJ. 2021 Sep 1;374:n2060
pubmed: 34470747
Nat Commun. 2020 Nov 12;11(1):5749
pubmed: 33184277
Euro Surveill. 2020 Dec;25(48):
pubmed: 33272357
Eur Respir J. 2017 Sep 27;50(3):
pubmed: 28954782
Nat Med. 2020 Aug;26(8):1205-1211
pubmed: 32546824
Lancet Child Adolesc Health. 2020 Sep;4(9):653-661
pubmed: 32593339
EClinicalMedicine. 2022 Feb;44:101287
pubmed: 35169689
J Intern Med. 2019 Oct;286(4):469-480
pubmed: 31259452
Lancet Reg Health Eur. 2021 Apr;3:100075
pubmed: 34027512
BMJ Open. 2021 May 3;11(5):e048038
pubmed: 33941636
BMJ. 2020 Aug 27;370:m3249
pubmed: 32960186
Euro Surveill. 2019 Jan;24(1):
pubmed: 30621817
Nat Med. 2022 Jan;28(1):193-200
pubmed: 34931076
PLoS One. 2013 Jul 10;8(7):e68323
pubmed: 23874585
Clin Infect Dis. 2020 Nov 5;71(8):1984-1987
pubmed: 32095810
Clin Infect Dis. 2015 Feb 1;60(3):333-7
pubmed: 25332078
Stat Med. 1998 Feb 28;17(4):407-29
pubmed: 9496720
JAMA Intern Med. 2021 Dec 1;181(12):1668-1670
pubmed: 34605853
Clin Infect Dis. 2010 Dec 15;51(12):1355-61
pubmed: 21058908
BMJ. 2021 Mar 31;372:n608
pubmed: 33789843
Euro Surveill. 2020 Jun;25(22):
pubmed: 32524957
Arch Dis Child. 2021 Feb 16;:
pubmed: 33593743